Board of directors (10)
Directors with a Section 16 filing in the last 13 months. “Since” is the first filing as a director; SEC data sets start in 2016.
Executive officers (9)
Company facts
- Chair
- Noel R. Wallace
- In S&P 500 since
- Mar 1957
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC industry
- Perfumes, Cosmetics & Other Toilet Preparations
- SEC filings
- EDGAR
Connections to other S&P 500 companies
Current directors and officers who also hold a role at another S&P 500 company.
- John T. CahillADSK · DirectorKHC · Director
- Martina HundmejeanGEV · DirectorPRU · Director
- Brian NewmanCVS · CFO
- C. Martin HarrisTMO · Director
- Christopher S. BoernerBMY · CEO
- Jennifer DanielsSTZ · Director
- Kimberly A. NelsonCMI · Director
- Noel R. WallaceAXP · Director
- Shane GrantLULU · Director
- Stanley J. Sutula IIICASY · Director
Major holders (5% or more)
Latest Schedule 13D/13G filing per holder. Holders that reported falling below 5% are not shown. Index funds usually report once a year.
No 5% holder filings parsed yet for this company.
Insider trades
Open-market purchases and sales reported on Form 4. Grants, option exercises and tax withholding are excluded.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2026 | Noel R. Wallace Chairman, President & CEO | Sale | 20,000 | $100.26 | $2.0M |
| Nov 4, 2026 | Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Sale | 19,938 | $98.74 | $2.0M |
| Nov 4, 2026 | John Hazlin Chief Growth Officer | Sale | 23,376 | $99.15 | $2.3M |
| Aug 24, 2026 | Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Sale | 10,000 | $92.05 | $921K |
| Aug 6, 2026 | John T. Cahill Director | Sale | 4,170 | $93.37 | $389K |
| Aug 5, 2026 | Noel R. Wallace Chairman, President & CEO | Sale | 161,021 | $92.52 | $14.9M |
| Aug 4, 2026 | Noel R. Wallace Chairman, President & CEO | Sale | 161,021 | $91.92 | $14.8M |
| May 15, 2026 | Gregory Malcolm EVP and Controller | Sale | 2,300 | $88.44 | $203K |
| May 7, 2026 | Sally Massey Chief People Officer | Sale | 8,599 | $87.41 | $752K |
| Feb 12, 2026 | Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Sale | 15,000 | $97.81 | $1.5M |
| Feb 11, 2026 | Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Sale | 35,000 | $94.61 | $3.3M |
| Feb 10, 2026 | John Hazlin Chief Growth Officer | Sale | 20,989 | $94.25 | $2.0M |
| Feb 6, 2026 | Gregory Malcolm EVP and Controller | Sale | 12,747 | $94.91 | $1.2M |
| Feb 5, 2026 | Sally Massey Chief People Officer | Sale | 15,851 | $95.03 | $1.5M |
| Feb 4, 2026 | Stanley J. Sutula III Chief Financial Officer | Sale | 97,843 | $94.27 | $9.2M |
| Feb 4, 2026 | Jennifer Daniels CLO and Secretary | Sale | 22,000 | $94.34 | $2.1M |
| Feb 4, 2026 | Noel R. Wallace Chairman, President & CEO | Sale | 45,568 | $93.91 | $4.3M |
| Nov 21, 2025 | Sally Massey Chief People Officer | Sale | 1,237 | $80.89 | $100K |
| May 15, 2025 | Sally Massey Chief People Officer | Sale | 2,250 | $88.97 | $200K |
| Feb 25, 2025 | Sally Massey Chief People Officer | Sale | 8,000 | $92.02 | $736K |
| Nov 26, 2024 | Gregory Malcolm EVP and Controller | Sale | 1,054 | $95.94 | $101K |
| Nov 22, 2024 | Noel R. Wallace Chairman, President & CEO | Sale | 33,333 | $95.00 | $3.2M |
| Nov 5, 2024 | Stanley J. Sutula III Chief Financial Officer | Sale | 45,410 | $94.11 | $4.3M |
| Nov 4, 2024 | Panagiotis Tsourapas COO, CD, EMEA, APac, Skin | Sale | 20,032 | $93.30 | $1.9M |
| Nov 1, 2024 | Stanley J. Sutula III Chief Financial Officer | Sale | 50,000 | $93.53 | $4.7M |
Board and executive changes
Every 8-K with Item 5.02 (departure, election or appointment of directors and officers). The text is the first paragraph of the item.
- Apr 9, 2026
Jennifer M. Daniels, who has served as Chief Legal Officer and Secretary of Colgate-Palmolive Company (the “Company”) since 2014, has communicated to the Company her intention to retire from the Company in 2026. As a result, on April 8, 2026, the Board of Directors of the Company (the “Board”) elected Betsy Fishbone, currently Executive Vice President, Deputy Chief Legal Officer of the Company, to the position of Chief Legal Officer and Secretary, effective June 1, 2026. Also effective June 1, 2026, the Board elected Ms. Daniels to the position of Vice Chair of the Company to provide for an orderly transition of the Chief Legal Officer and Secretary responsibilities to Ms. Fishbone. 2
Read the 8-K filing - Mar 12, 2026
On March 12, 2026, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate-Palmolive”) elected Christopher S. Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company (“Bristol Myers Squibb”), to the Colgate-Palmolive Board, effective March 15, 2026. Dr. Boerner, 55, has served as Chief Executive Officer of Bristol Myers Squibb, a global biopharmaceutical company, since November 2023 and as Board Chair since April 2024 and will bring extensive global business leadership experience and expertise in the pharmaceutical and healthcare industries, complementary industries, to Colgate-Palmolive’s Board. He previously served as Executive Vice President, Chief Operating Officer of Bristol Myers Squibb in 2023 and as Executive Vice President, Chief Commercialization Officer from 2018 to 2023.
Read the 8-K filing - May 29, 2025
On May 29, 2025, Colgate-Palmolive Company (the “Company”) announced that its Board of Directors (the “Board”) had elected Shane Grant as the Company’s Chief Operating Officer, Americas, reporting to Chairman, President and Chief Executive Officer, Noel R. Wallace, effective June 16, 2025. Mr. Grant, 50, will join the Company from Group Danone (“Danone”), a leading global food and beverage company, where he has been Group Deputy CEO, CEO Americas and EVP Dairy, Plant-Based and Global Sales since January 2023. Mr. Grant joined Danone in May 2020 and served as Executive Vice President & CEO, Danone North America. He assumed the additional role of interim co-CEO, Danone in March 2021. Prior to Danone, Mr. Grant spent almost 20 years with The Coca-Cola Company, where he held various leadership roles of increasing responsibility in category leadership, commercial and general management.
Read the 8-K filing - Feb 15, 2024
On February 15, 2024, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate”) elected Brian Newman, Executive Vice President and Chief Financial Officer of United Parcel Service, Inc. (“UPS”), to the Colgate Board, effective March 15, 2024. Mr. Newman, 55, will bring extensive financial and global business leadership experience and expertise in the consumer products industry to Colgate’s Board. Prior to joining UPS in 2019, Mr. Newman spent 26 years at PepsiCo, Inc. (“PepsiCo”), where he served in a variety of finance leadership roles spanning Europe, Asia and North and South America. He also served as Executive Vice President for PepsiCo’s Global Operations, responsible for global operations including supply chain, global procurement, global security, enterprise risk management and transformation and as PepsiCo’s Chief Strategy Officer. Mr.
Read the 8-K filing - Sep 15, 2023
At its meeting on September 13, 2023 (the “Effective Date”), the Board of Directors of Colgate-Palmolive Company (the “Board”) renewed the Colgate-Palmolive Company Executive Severance Plan (the “Plan”) on substantially the same terms and conditions as previously in effect, as described in the Company’s Proxy Statement for the 2023 Annual Meeting of Stockholders, with the following changes: (1) the Plan will have a term of three years, subject to automatic extension for an additional year on each anniversary of the Effective Date unless the Board otherwise determines; and (2) in order to be eligible to participate in the Plan, executives are required to agree not to compete with the Company for a period of one year following their termination of employment. A copy of the Plan, as renewed, is attached as Exhibit 10-A to this Current Report on Form 8-K.
Read the 8-K filing - Aug 18, 2023
On August 18, 2023, Michael B. Polk resigned from Colgate-Palmolive Company’s Board of Directors for personal reasons. The Company is filing this 8-K pursuant to
Read the 8-K filing - Jan 30, 2023
On January 30, 2023, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate”) elected Steven Cahillane, Chairman of the Board, President and Chief Executive Officer of Kellogg Company (“Kellogg”), to the Colgate Board, effective February 1, 2023. Mr. Cahillane, 57, will bring extensive global business leadership experience and expertise in the consumer products and health and nutrition industries to Colgate’s Board. Mr. Cahillane joined Kellogg, a global snacks, cereal and frozen foods company operating in more than 180 countries, as Chief Executive Officer in 2017 and became Chairman of the Board in 2018. Prior to joining Kellogg, from 2014 to 2017, Mr. Cahillane served as President and Chief Executive Officer of The Nature’s Bounty Co. Mr.
Read the 8-K filing - Jun 13, 2022
Change in Principal Accounting Officer . On June 9, 2022, the Board of Directors of Colgate-Palmolive Company (the "Company") elected Gregory Malcolm Vice President and Controller of the Company, effective June 30, 2022. In this capacity, Mr. Malcolm will serve as the Company's principal accounting officer. Philip G. Shotts, who has served as the Company's Controller since June 2018, will continue as Senior Vice President, Finance, also effective June 30, 2022. Mr. Malcolm, 55, joined the Company in 1999 and has held key financial roles at the Company, including serving as Vice President, Assistant Controller since October 2021. He previously served as Vice President, Chief Business Services Officer from June 2019 to September 2021 and as Vice President, Corporate Audit from November 2016 to June 2019.
Read the 8-K filing - Apr 11, 2022
Following engagement with stockholders, on April 8, 2022, the Board of Directors of Colgate-Palmolive Company (“Colgate”) adopted a policy that Colgate will not execute any new severance agreement with an executive officer that provides for cash severance benefits exceeding 2.99 times the sum of the executive officer’s base salary plus target annual bonus opportunity, without seeking stockholder ratification of the agreement.
Read the 8-K filing - Mar 11, 2021
On March 11, 2021, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate”) elected Kimberly A. Nelson, former Senior Vice President, External Relations of General Mills, Inc. (“General Mills”), to the Colgate Board. Ms. Nelson, 58, will bring extensive leadership experience, in-depth knowledge of the fast-moving consumer goods industry and a strong focus on sustainability and social responsibility to Colgate’s Board. Ms. Nelson joined General Mills in 1988 and held several senior brand and general management roles before becoming Senior Vice President, External Relations in 2010. She retired from General Mills in 2018. Ms. Nelson will receive compensation as a non-employee director in accordance with Colgate’s director compensation program described in Colgate’s proxy statement filed with the Securities and Exchange Commission on March 25, 2020.
Read the 8-K filing - Oct 30, 2020
On October 28, 2020, the Board of Directors (the “Board”) of Colgate-Palmolive Company (the “Company”) elected Stanley J. Sutula III as the company’s Chief Financial Officer, reporting to Chairman, President and Chief Executive Officer, Noel R. Wallace, effective November 9, 2020. Mr. Sutula will succeed Henning I. Jakobsen who will remain at the Company until December 31, 2020 to provide for an orderly transition and will then retire from the Company and return to his home in Denmark. Mr. Sutula, 55, will join the Company from Pitney Bowes Inc. (“Pitney Bowes”), a global technology company, where he has been Executive Vice President and Chief Financial Officer since February 2017. Prior to Pitney Bowes, Mr.
Read the 8-K filing - Mar 11, 2020
Consistent with previously announced succession plans, on March 11, 2020, Colgate-Palmolive Company (“Colgate”) announced that Mr. Ian Cook will retire from his positions as Executive Chairman and a director of Colgate, and that the Board of Directors (the “Board”) has unanimously elected Mr. Noel R. Wallace, currently Chief Executive Officer and President and a member of the Board of Directors, to the additional role of Chairman of the Board, in each case effective April 1, 2020. Also at its meeting on March 11, 2020, Colgate’s Board elected Ms. Martina Hund-Mejean, former Chief Financial Officer of Mastercard, Inc. (“Mastercard”), to the Colgate Board. Ms. Hund-Mejean was appointed to the Board’s Audit and Finance Committees. Ms. Hund-Mejean, 59, brings extensive leadership experience and financial expertise to the Colgate Board. Ms.
Read the 8-K filing - Jun 24, 2019
On June 18, 2019, Mr. P. Justin Skala, Executive Vice President, Chief Growth & Strategy Officer, announced his intention to retire from Colgate-Palmolive Company (the “Company”) effective August 1, 2019 to assume a leadership role outside the Company. 2
Read the 8-K filing - May 15, 2019
On May 10, 2019, the Company’s stockholders approved the Colgate-Palmolive Company 2019 Incentive Compensation Plan (the “Plan”) at the Annual Meeting of Stockholders (the “Annual Meeting”). A detailed description of the Plan was included in the Company’s definitive proxy statement, filed with the Securities and Exchange Commission on March 27, 2019 (the “Proxy Statement”). A copy of the Plan was filed as Annex C to the Proxy Statement.
Read the 8-K filing - Mar 20, 2019
Director or officer change (Item 5.02). Open the filing for details.
Read the 8-K filing
Show 12 older changes
- Feb 21, 2019
On February 21, 2019, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate”) elected Lisa M. Edwards, Executive Vice President, Strategic Business Operations, Customer and Partner Engagement of Salesforce.com, Inc. (“Salesforce”), to the Board of Directors effective March 1, 2019. Ms. Edwards, 51, will bring extensive leadership experience and expertise in information technology, e-commerce and digital transformation to Colgate’s Board. Ms. Edwards joined Salesforce in 2012 as Executive Vice President, Finance, Head of Global Corporate Services and Chief Procurement Officer, and has served in her current role since 2017. Ms. Edwards previously served in several senior management roles at Visa Inc., including as Senior Vice President and Head of Global Business Development and IP Strategy.
Read the 8-K filing - Feb 11, 2019
On February 11, 2019, Colgate-Palmolive Company (“Colgate” or the “Company”) announced that the Company’s Board of Directors (the “Board”) has elected Noel R. Wallace, 54, as President and Chief Executive Officer and a director of the Company, in each case effective April 2, 2019. Effective April 2, 2019, Mr. Ian Cook, 66, who has served as Chairman and Chief Executive Officer of Colgate since July 2018 after serving as Chairman, President and Chief Executive Officer from January 2009 to July 2018 and President and Chief Executive Officer and director from July 2007 through December 2008, will become Executive Chairman of the Company and will remain Chairman of the Board for a period of up to 12 months in connection with the leadership transition. Noel R. Wallace was appointed President and Chief Operating Officer in July 2018.
Read the 8-K filing - Oct 10, 2018
Director or officer change (Item 5.02). Open the filing for details.
Read the 8-K filing - Sep 18, 2018
At its meeting on September 13, 2018, the Board of Directors of Colgate-Palmolive Company (the “Board”) renewed the Colgate-Palmolive Company Executive Severance Plan (the “Plan”) for an additional term to expire on December 31, 2023, on substantially the same terms and conditions as previously in effect, as described in the Company’s Proxy Statement for the 2018 Annual Meeting of Stockholders, with the following change: The Board amended the Plan to provide that if a participant is subject to the so-called “golden parachute” tax under Section 4999 of the Internal Revenue Code, either (1) the participant will receive all payments and pay the golden parachute tax or (2) the payments to the participant will be reduced such that the golden parachute tax does not apply, whichever approach yields the best after-tax outcome for the participant.
Read the 8-K filing - Jul 11, 2018
On July 11, 2018, the Board of Directors of Colgate-Palmolive Company (the “Company”) elected Mr. Noel R. Wallace to the position of President and Chief Operating Officer and Mr. P. Justin Skala to the position of Executive Vice President, Chief Growth & Strategy Officer. Mr. Ian Cook, who has served as the Company’s President and Chief Executive Officer since July 1, 2007 and as Chairman, President and Chief Executive Officer since January 1, 2009, will continue as the Company’s Chairman and Chief Executive Officer. Mr. Wallace, 53, had been Chief Operating Officer, Global Innovation & Growth and Hill’s Pet Nutrition since March 2016 and served as President, Colgate-Latin America from October 2013 through March 2016 and as President, North America and Global Sustainability from February 2010 through September 2013. Mr.
Read the 8-K filing - Jun 18, 2018
On June 18, 2018, the Board of Directors of Colgate-Palmolive Company (the “Company”) elected Mr. Philip G. Shotts Vice President and Controller of the Company. In this capacity Mr. Shotts will serve as the Company’s principal accounting officer. Mr. Shotts, 63, joined the Company in 1990 and has held key financial roles at the Company, serving as its Vice President and Assistant Controller since 2003.
Read the 8-K filing - May 4, 2018
On May 4, 2018, the Board of Directors of Colgate-Palmolive Company (the “Company”) elected Mr. Henning I. Jakobsen to the position of Chief Financial Officer. In this capacity Mr. Jakobsen will continue to serve as the Company’s principal accounting officer. Mr. Dennis J. Hickey, 69, who has served as the Company’s Chief Financial Officer since January 2011, will continue as the Vice Chairman of the Company. Mr. Jakobsen, 57, has served as the Company’s Vice President and Corporate Controller since October 2017. Mr. Jakobsen joined the Company in 1989 and held key financial and operating roles at the subsidiary and division levels, including Vice President, Finance for the Company’s U.S. operations, before leaving the Company in 2006 to become Chief Financial Officer of Chr. Hansen, a Denmark-based multinational bioscience organization. Mr.
Read the 8-K filing - Sep 28, 2017
Change in Principal Accounting Officer . At its meeting on September 26, 2017, the Board of Directors of Colgate-Palmolive Company (the “Company”) elected Henning I. Jakobsen, currently Vice President and General Manager for the Company’s Nordic Hub, as Vice President and Corporate Controller of the Company, effective October 1, 2017. Victoria Dolan, who has served as the Company’s Corporate Controller since February 2011, will continue as the Chief Transformation Officer of the Company. Mr. Jakobsen, 57, joined the Company in 1989 and held key financial and operating roles at the subsidiary and division levels, including Vice President, Finance for the Company’s U.S. operations, before leaving the Company in 2006 to become Chief Financial Officer of Chr. Hansen, a Denmark-based multinational bioscience organization. Mr.
Read the 8-K filing - Dec 8, 2016
On December 8, 2016, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate”) elected Mr. Charles A. Bancroft, Executive Vice President, Chief Financial Officer and Global Business Operations of Bristol-Myers Squibb Company (“Bristol-Myers Squibb”), to the Board of Directors effective January 1, 2017. Mr. Bancroft, 57, will bring extensive leadership experience and financial expertise to Colgate’s Board. Mr. Bancroft joined Bristol-Myers Squibb in 1984 and has since held positions of increasing responsibility within the finance organization, including international assignments, as well as senior leadership positions in their global pharmaceutical business. Mr. Bancroft was appointed Chief Financial Officer in 2010 and has served in his current role since 2016. Prior to joining Bristol-Myers Squibb, Mr. Bancroft was an auditor with KPMG. Beginning in 2017, Mr.
Read the 8-K filing - Mar 28, 2016
On March 24, 2016, the Board of Directors of Colgate-Palmolive Company (the “Company”) elected Mr. P. Justin Skala to the position of Chief Operating Officer, North America, Europe, Africa/Eurasia and Global Sustainability, Mr. Noel R. Wallace to the position of Chief Operating Officer, Global Innovation & Growth and Hill’s Pet Nutrition and Mr. Franck J. Moison to the position of Vice Chairman overseeing the Company’s business in Asia Pacific and Latin America and Business Development, all effective April 1, 2016. Mr. Skala, 56, had been President, Colgate-North America and Global Sustainability since October 2013 and served as President, Colgate-Latin America from July 2010 through September 2013. Mr.
Read the 8-K filing - Mar 14, 2016
On March 14, 2016, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate”) elected Dr. C. Martin Harris to the Board of Directors. C. Martin Harris, MD, 59, brings extensive leadership experience and expertise in the healthcare and information technology fields to Colgate’s Board. Dr. Harris has been Chief Information Officer and Chairman of the Information Technology Division of The Cleveland Clinic Foundation since 1996 and is a Staff Physician for The Cleveland Clinic Hospital and The Cleveland Clinic Foundation Department of General Internal Medicine. Since 2000, he has also served as Executive Director of e-Cleveland Clinic, a series of e-health clinical programs offered over the Internet. Dr. Harris will receive compensation in accordance with Colgate’s director compensation program for non-employee directors. On March 10, 2016, Delano E.
Read the 8-K filing - Mar 10, 2016
On March 10, 2016, J. Pedro Reinhard resigned from Colgate-Palmolive Company's Board of Directors. The Company is filing this 8-K pursuant to
Read the 8-K filing
Proxy statements (DEF 14A): 2026 · 2025 · 2024 · 2023 · 2022 · 2021
Share price
Annual financials
From the company's 10-K XBRL data (SEC companyfacts).
| Fiscal year | Revenue | Net income | Margin | Diluted EPS | Total assets |
|---|---|---|---|---|---|
| FY2025 | $20.4B | $2.1B | 10.5% | $2.63 | $16.3B |
| FY2024 | $20.1B | $2.9B | 14.4% | $3.51 | $16.0B |
| FY2023 | $19.5B | $2.3B | 11.8% | $2.77 | $16.4B |
| FY2022 | $18.0B | $1.8B | 9.9% | $2.13 | $15.7B |
| FY2021 | $17.4B | $2.2B | 12.4% | $2.55 | $15.0B |
| FY2020 | $16.5B | $2.7B | 16.4% | $3.14 | $15.9B |
| FY2019 | $15.7B | $2.4B | 15.1% | $2.75 | $15.0B |
| FY2018 | $15.5B | $2.4B | 15.4% | $2.75 | $12.2B |
Former directors and officers (24)
People who stopped filing as an insider of this company. “Last filing” is the last Form 3/4/5, an upper bound on when they left.